Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer

In patients with non-small cell lung cancer (NSCLC) harboring a fusion of the neurotrophic receptor kinase (NTRK) gene 1 or 3, treatment with tropomyosin kinase (TRK) inhibitors have shown promising results, however so far no data on efficacy of these agents in patients with NSCLC and NTRK2 fusion a...

Descripción completa

Detalles Bibliográficos
Autores principales: Frehner, Lorenz, Haefliger, Simon, Cerciello, Ferdinando, Grob, Tobias, Schmid, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601816/
https://www.ncbi.nlm.nih.gov/pubmed/37900816
http://dx.doi.org/10.1159/000533572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601816/
https://www.ncbi.nlm.nih.gov/pubmed/37900816
http://dx.doi.org/10.1159/000533572

Ejemplares similares